Pharmaceutical Executive March 5, 2021
Michael Wong

Dr. Amy P. Abernethy talks about her career moves from academia to industry to the US Food & Drug Administration.

Michael Wong speaks to Dr. Amy P. Abernethy about making the transition from oncologist to the Agency’s Principal Deputy Commissioner/Acting CIO of FDA.

Michael Wong: While some of my friends have moved from academia to industry, like you did as a Professor at Duke University to a C-Suite role at Flatiron Health, why did you join FDA and what were the key steps to make this transition?

Amy Abernethy: While my career has evolved across settings, my core focus has not changed: how do we improve the care of the patient sitting in front of me, especially by learning from...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Interview / Q&A, Physician, Provider, Trends
Health systems ramp up AI partnerships to tackle doctor burnout
Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
How physician incentive bonuses have changed over the last 5 years
Is peer coaching the solution to physician burnout?
Why independent physicians could have more power than employed counterparts: Viewpoint

Share This Article